PANACEABIO Financial Statements

PANACEABIO Half Yearly Results

Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar Mar-2021 Mar-2020 Mar-2018 Mar-2017
Growth matrix (%)        
Revenue growth 14.80 (8.20) 8.97 (17)
Op profit growth 144 (63) 35.40 (44)
EBIT growth 130 (48) (16) (30)
Net profit growth (24) 163 35.80 198
Profitability ratios (%)        
OPM 12.30 5.76 14.30 11.50
EBIT margin 6.56 3.28 5.81 7.55
Net profit margin (24) (36) (12) (10)
RoCE 4.61 1.41 2.26 2.56
RoNW 247 (19) (5.60) (3.40)
RoA (4.10) (3.80) (1.20) (0.80)
Per share ratios ()        
EPS (24) (32) -- --
Dividend per share -- -- -- --
Cash EPS (32) (39) (22) (20)
Book value per share (37) 32.50 50.40 58.10
Valuation ratios        
P/E (7.40) (3.20) -- --
P/CEPS (5.60) (2.60) (11) (7.40)
P/B (4.80) 3.10 4.86 2.54
EV/EBIDTA 20.40 21.70 27.50 18
Payout (%)        
Dividend payout -- -- -- --
Tax payout 1.36 10.70 14.90 (18)
Liquidity ratios        
Debtor days 44.70 68.60 85.60 95.20
Inventory days 94 162 200 208
Creditor days (140) (169) (189) (165)
Leverage ratios        
Interest coverage (0.20) (0.10) (0.30) (0.40)
Net debt / equity (3) 3.28 2.97 2.75
Net debt / op. profit 8.92 20.80 10.90 15.70
Cost breakup ()        
Material costs (33) (29) (32) (27)
Employee costs (25) (26) (26) (27)
Other costs (30) (39) (29) (34)
Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar( In .Cr) Mar-2021 Mar-2020 Mar-2018 Mar-2017
Revenue 625 544 593 544
yoy growth (%) 14.80 (8.20) 8.97 (17)
Raw materials (205) (157) (187) (150)
As % of sales 32.80 28.80 31.60 27.50
Employee costs (156) (142) (152) (148)
As % of sales 25 26.20 25.60 27.20
Other costs (187) (214) (169) (184)
As % of sales 30 39.30 28.60 33.80
Operating profit 76.60 31.40 84.50 62.40
OPM 12.30 5.76 14.30 11.50
Depreciation (46) (43) (59) (68)
Interest expense (185) (174) (101) (101)
Other income 9.98 29.70 8.44 46.60
Profit before tax (144) (156) (66) (60)
Taxes (2) (17) (9.90) 11
Tax rate 1.36 10.70 14.90 (18)
Minorities and other (1.50) (6.40) 2.02 (14)
Adj. profit (148) (179) (74) (62)
Exceptional items -- (15) -- 7.72
Net profit (148) (194) (74) (54)
yoy growth (%) (24) 163 35.80 198
NPM (24) (36) (12) (10)
Switch to
Tabular Data
Graph
Y/e 31 Mar ( In .Cr) Mar-2021 Mar-2020 Mar-2018 Mar-2017
Profit before tax (144) (156) (66) (60)
Depreciation (46) (43) (59) (68)
Tax paid (2) (17) (9.90) 11
Working capital (506) 12.90 30.30 202
Other operating items -- -- -- --
Operating cashflow (698) (203) (104) 85.20
Capital expenditure 222 (364) (88) (98)
Free cash flow (477) (567) (193) (12)
Equity raised 556 1,256 996 911
Investments (57) (27) (15) (8.70)
Debt financing/disposal 37.40 (71) 55.30 23.50
Dividends paid -- -- -- --
Other items -- -- -- --
Net in cash 59.90 591 844 913
Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar ( In .Cr) Mar-2021 Mar-2020 Mar-2019 Mar-2018
Equity capital 27.80 59.90 15.80 15.80
Preference capital -- -- -- --
Reserves (256) 139 335 293
Net worth (229) 199 350 309
Minority interest
Debt 820 742 647 941
Deferred tax liabilities (net) 120 134 147 209
Total liabilities 708 1,072 1,141 1,455
Fixed assets 643 681 828 989
Intangible assets
Investments 0.07 5.58 5.33 7.28
Deferred tax asset (net) 120 136 167 219
Net working capital (191) 159 117 217
Inventories 174 148 81.40 334
Inventory Days 102 99.10 -- 206
Sundry debtors 84.70 68.50 88.70 136
Debtor days 49.50 46 -- 83.70
Other current assets 141 395 329 98.30
Sundry creditors (222) (199) (270) (277)
Creditor days 130 133 -- 171
Other current liabilities (369) (254) (112) (75)
Cash 136 89.80 23.50 23.20
Total assets 708 1,072 1,141 1,455
Switch to
Consolidated
Standalone


Particulars ( Rupees In Crores.) Mar-2022 Sep-2021 Mar-2021 Sep-2020 Mar-2020
Gross Sales 297 365 310 315 293
Excise Duty -- -- -- -- --
Net Sales 297 365 310 315 293
Other Operating Income -- -- -- -- --
Other Income 1,682 5.26 6.74 3.32 21.40
Total Income 1,979 370 317 318 315
Total Expenditure ** 315 360 294 256 282
PBIDT 1,664 9.73 22.80 62.40 32.90
Interest 82.80 98.10 92.60 92.70 91.70
PBDT 1,581 (88) (70) (30) (59)
Depreciation 21.70 22 22.90 22.70 20.80
Minority Interest Before NP -- -- -- -- --
Tax 401 -- 2.29 0.03 40
Deferred Tax (30) -- (0.80) 0.40 (29)
Reported Profit After Tax 1,188 (110) (94) (53) (91)
Minority Interest After NP 0.02 -- 0.04 -- --
Net Profit after Minority Interest 1,188 (110) (94) (53) (91)
Extra-ordinary Items 1,676 -- -- -- --
Adjusted Profit After Extra-ordinary item (488) (110) (94) (53) (91)
EPS (Unit Curr.) 194 (18) -- (24) --
Book Value (Unit Curr.) -- -- -- -- --
Dividend (%) -- -- -- -- --
Equity 6.13 6.13 6.13 6.13 6.13
Public Shareholding (Number) -- -- -- -- --
Public Shareholding (%) -- -- -- -- --
Pledged/Encumbered - No. of Shares -- -- -- -- --
Pledged/Encumbered - % in Total Promoters Holding -- -- -- -- --
Pledged/Encumbered - % in Total Equity -- -- -- -- --
Non Encumbered - No. of Shares -- -- -- -- --
Non Encumbered - % in Total Promoters Holding -- -- -- -- --
Non Encumbered - % in Total Equity -- -- -- -- --
PBIDTM(%) 561 2.67 7.36 19.80 11.20
PBDTM(%) -- -- -- -- --
PATM(%) 401 (30) (30) (17) (31)
Open ZERO Brokerage Demat Account
Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity